General Notes
This product (Catalog No. DPABH-23161) is a rabbit-derived polyclonal antibody raised against human MRPL19. This antibody exhibits cross-reactivity with MRPL19 from mouse and rat. It has been affinity purified by Protein A. Mitochondrial ribosomal protein L19 (MRPL19) is a nuclear-encoded protein component of the large 39S subunit of the human mitochondrial ribosome (mitoribosome), which is responsible for translating 13 essential proteins of the oxidative phosphorylation system within mitochondria. Encoded by the MRPL19 gene located on chromosome 2p12, it belongs to the bacterial ribosomal protein bL19 family and contributes to the structural integrity and function of the mitoribosome, which has a protein-heavy composition (approximately 75% protein by mass, unlike bacterial ribosomes). The protein, consisting of 292 amino acids with a molecular mass of about 33.5 kDa, is ubiquitously expressed across human tissues, with elevated levels in organs like the heart, liver, skeletal muscle, kidney, pancreas, and HeLa cells. MRPL19 plays a critical role in mitochondrial translation processes, including initiation, elongation, and termination, as part of the mature 55S mitoribosome assembled from a 28S small subunit (29 proteins + 12S rRNA) and the 39S large subunit (52 proteins + 16S rRNA + mt-tRNA^Val). Structural studies have revealed its positioning within the mitoribosome, highlighting adaptations unique to mammalian mitochondria, such as expanded protein content for enhanced stability and quality control. Beyond its core function, genetic variants in MRPL19 have been associated with neurodevelopmental disorders; specifically, risk haplotypes in the intergenic region between MRPL19 and the neighboring C2orf3 gene at the DYX3 locus on 2p12 confer susceptibility to dyslexia, with heterozygous carriers showing reduced MRPL19 expression and odds ratios up to 5.2 for severe cases in European cohorts. Additionally, polymorphisms in MRPL19 influence language skills and receptive vocabulary in children with autism spectrum disorders, underscoring its potential role in cognitive and linguistic traits. Overexpression of MRPL19 has been associated with poor prognosis in lung adenocarcinoma.
DPABH-23161 is suitable for use in WB 1 (1000-3000), IF/ICC 1 (100-1:500), IHC 1 (50-1:200) applications.
DPABH-23161 is supplied as a liquid formulation in Phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.